As part of the supply agreement, BB-NCIPD will provide Stablepharma with their bulk Tetadif vaccine which will then be converted to the StablevaX formulation to produce a thermally stable version.
The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU counterparts, including eligibility to lead projects.